Conjugation Of The MCR1 Ligand with Cytotoxic Drugs For Targeted Melanoma Therapy

Conjugation Of The MCR1 Ligand with Cytotoxic Drugs For Targeted Melanoma Therapy

Publication date: Jul 24, 2019

This invention enables use of cytotoxic drugs that may be less likely to result in melanoma treatment resistance but would otherwise lack selectivity to . ..

Concepts Keywords
Conjugation Chemotherapy
Cytotoxic Melanoma
Melanoma Oncology
Cancer treatments
Antineoplastic drugs
Cancer
Clinical medicine
Medicine
Cytotoxic drugs melanoma
Melanoma treatment
Melanoma Therapy
Targeted therapy
Cancer immunotherapy

Semantics

Type Source Name
disease MESH Melanoma
disease DOID Melanoma
pathway BSID Melanoma

Leave a Comment

Your email address will not be published. Required fields are marked *